Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsRotigotine Drug

CAS No 58349 17 0 Rotigotine Drug Intermediate GMP Condition

I'm Online Chat Now

CAS No 58349 17 0 Rotigotine Drug Intermediate GMP Condition

China CAS No 58349 17 0 Rotigotine Drug Intermediate GMP Condition supplier

Large Image :  CAS No 58349 17 0 Rotigotine Drug Intermediate GMP Condition

Product Details:

Place of Origin: China
Certification: GMP condition

Payment & Shipping Terms:

Minimum Order Quantity: 10KGS
Packaging Details: Drum
Contact Now
Detailed Product Description
CAS: 58349-17-0 Usage: Rotigotine Intermediate
Molecular Formula: C11H15NO . HCl Molecular Formula -: C11H16ClNO
High Light:

32940 15 1

CAS No. : 58349-17-0 Rotigotine Intermediate GMP condition

 

Chemical Name : ( S ) - 2 - Amino - 5 - methoxyteterlin Hydrochloride

 

CAS No . : 58349-17-0

 

Synonyms : ( S ) - 2 - Amino - 5 - methoxyteterlin HCl ; ( S ) - 5 - Methoxy - 1 , 2 , 3 , 4 - tetrahydronaphthalen-2-amine hydrochloride ; ( S ) - 5 - Methoxy - 1 , 2 , 3 , 4 - tetrahydronaphthalen-2-amine HCl

 

Molecular Formula : C11H15NO . HCl ;  C11H16ClNO

 

Molecular Weight : 213.7

 

Usage : Rotigotine Intermediate

 

Description : Rotigotine is the active pharmaceutical ingredient (API) of branded drug Neupro. The developing history of Rotigotine is quite long. It was developed in 1985 by University of Groningen. Aderis Pharmaceuticals continued its development. A German company called Schwarz Pharma (now a subsidiary of UCB S.A.) got worldwide development and commercialization rights from Aderis in 1998. Rotigotine is used to treat Parkinson’s disease (PD) and restless legs syndrome (RLS). Rogitine is maybe also useful to treat depression. Rogotine (Neupro) was approved by EMEA in Europe in 2006 and by FDA in USA in 2007.

 

( S ) - 2 - Amino - 5 - methoxyteterlin Hydrochloride CAS No . : 58349-17-0 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some are protected by the patents in some countries or areas. We strictly obey the laws. The buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of the patent infringement by themselves.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

 

 

 

Tag:

32940 15 1

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)